期刊文献+

CPPαFP缩糠胺席夫碱铜配合物的合成及其与DNA相互作用 被引量:4

Synthesis of copper complex of Schiff base derived from CPPαFP and furfuryl amine and its interaction with DNA
下载PDF
导出
摘要 合成出一种新型酰基吡唑啉酮席夫碱试剂(HL):1-对氯苯基-3-苯基-4-(α-呋喃甲酰基)-吡唑啉酮-5缩糠胺席夫碱及其铜配合物。由元素分析、络合滴定法、红外光谱、热重谱、质谱和核磁共振氢谱对配体和配合物的结构进行了表征并推测出配合物组成为CuL2,同时对该配合物与小牛胸腺DNA之间的相互作用进行了研究。结果表明:在测试条件下,配体以酮式和烯醇式共存。配位时酮式结构可能转化为烯醇式结构,按去质子的方式以羟基上的氧负离子和亚胺基上的氮原子双齿形式与铜中心离子成键;与小牛胸腺DNA作用实验结果显示:配合物主要以插入方式与CT-DNA相互作用,嵌入CT-DNA的碱基对中。 In this paper, a novel Sehiff base(HL) derived from 1-(p-chloro-phenyl)-3-phenyl-4-(α-furoyl )-pyrazolo-ne-5 with furfuryl amine and its copper complex have been synthesized in the nonaqueous solvent. Their molecular structures were characterized by elemental analysis, complexometrie titration, IR, TG, MS, 1HNMR and molar conductance measurements. The formula of complex was confirmed to be CuLz. The interaction of the complex with calf thymus DNA was investigated by fluorescence spectroscopy and viscosity measurement. The results of structural characterization showed that the novel ligand coexisted in both the ketoform structure and enolform structure under the testing conditions, and the ketoform structure might change into the enolform structure after being subjected to coordination and being bonded with copper central ion by enolic oxygen negative ion losing one proton and nitrogen at- om of imine group in bis-eog form. The interaction with DNA experiment indicate-d that the interaction of the complex with CT-DNA was mainly of the intercalation mode by inserting the base pair of CT-DNA.
出处 《化学研究与应用》 CAS CSCD 北大核心 2012年第8期1186-1191,共6页 Chemical Research and Application
基金 黑龙江省教育厅科技项目(12511084)资助
关键词 酰基吡唑啉酮 席夫碱 铜配合物 合成 CT-DNA acylpyrazolone Schiff base copper complex synthesis calf thymus DNA
  • 相关文献

参考文献4

二级参考文献35

  • 1张欣,朱华玲,徐海珍,王瑾玲.1-苯基-3-甲基-4-苯甲酰基-5-吡唑啉酮(HPMBP)缩甘氨酸甲酯的合成、表征和晶体结构[J].有机化学,2004,24(2):195-198. 被引量:8
  • 2王瑾玲,丁峰,郁铭.1-苯基-3-甲基-4-苯甲酰基-5-吡唑啉酮与对氨基苯乙酮的缩合反应、量化计算和抑菌活性[J].有机化学,2004,24(11):1423-1428. 被引量:14
  • 3Fu LW, Deng ZA, Pan QC, et al. Screening and discovery of novel MDR modifiers from naturally occurring bisbenzylisoquinoline alkaloids [J]. Anticancer Res, 2001,21(4A):2273-2280.
  • 4Borst P. Multidrug resistant proteins [J]. Semin Cancer Biol, 1997,8 (3):131-134.
  • 5Penning TD, Talley J J, Bertenshaw SR, et al. Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-[5-(4-methylphenyl)- 3-(trifluoromethyl)-1H-pyrazol-1-yl]benze nesulfonamide (SC-58635, celecoxib) [J]. J Med Chem, 1997,40(9):1347-1365.
  • 6Regan J, Breitfetder S, Cirillo P, et al. Pyrazole urea-based inhibitors of p38 MAP kinase: from lead compound to clinical candidate [J]. J Med Chem, 2002,45(14):2994-3008.
  • 7Pevarelle P, Brasca MG, Amici R, et al. 3-Aminopyrazole inhibitors of CDK2/cyclin A as antitumor agents. 1. Lead finding [J]. J Med Chem, 2004,47(13):3367-3380.
  • 8Kakiuchi Y, Sasaki N, Satoh-Masuoka M, et al. A novel pyrazolone, 4,4-dichloro-1 -(2,4-dichlor ophenyl)-3-methyl-5-pyr azolone, as a potent catalytic inhibitor of human telomerase [J]. Biochem Biophys Res Commun, 2004,320(4):1351-1358.
  • 9Bekhit AA, Ashour HM, Guemei AA. Novel pyrazole derivatives as potential promising anti-inflammatory antimicrobial agents [J]. Arch Pharm (Weinheim), 2005,338(4):167-174.
  • 10Fan X, Zhang X, Zhou L, et al. A pyrimidine-pyrazolone nucleoside chimera with potent in vitro anti-orthopoxvirus activity [J]. Bioorg Med Chem Lett, 2006,16(12):3224-3228.

共引文献29

同被引文献44

引证文献4

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部